Olaris Company

Olaris is on a mission to revolutionize how diseases are diagnosed and treated through the combination of metabolomics and machine learning
Technology: Biopharma, Biotechnology, Health Care
Industry: Early Drug Development
Headquarters: Framingham, Massachusetts, United States
Founded Date: 2013-06-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 3
Estimated Revenue: $1M to $10M
Last Funding Date: 2021-09-23
Last Funding Type: Series B

Visit Website
info@myolaris.com
Register and Claim Ownership